Tailored Therapy for Hodgkin Lymphoma Using Early Interim Therapy PET for Therapy Decision.

NCT00392314 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

365

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin Lymphoma

Interventions

OTHER: PET/CT post 2 cycles of chemotherapy

Sponsor

Rambam Health Care Campus

Collaborators

[object Object]
[object Object]